UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 1, 2018

 

 

HOUGHTON MIFFLIN HARCOURT COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36166   27-1566372

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

125 High Street

Boston, MA

  02110
(Address of principal executive offices)   (Zip Code)

(617) 351-5000

(Registrant’s telephone number, including area code)

NOT APPLICABLE

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 2.01

Completion of Acquisition or Disposition of Assets.

On October 1, 2018, Houghton Mifflin Harcourt Publishing Company (“HMH Sub”), a wholly owned subsidiary of Houghton Mifflin Harcourt Company (the “Company” and together with HMH Sub, the “Sellers”), completed the previously announced sale of all of the assets, including intellectual property, used primarily in its Riverside clinical and standardized testing business (the “Business”) pursuant to the Asset Purchase Agreement, dated September 12, 2018 and as amended on October 1, 2018 (the “Agreement”) with Riverside Assessments, LLC (the “Purchaser”), for cash consideration received by the Sellers of approximately $140.0 million and the Purchaser’s assumption of all liabilities relating to the Business subject to specified exceptions (collectively, the “Transaction”). The results of the Business were previously reported in the Company’s Education segment.

The foregoing description is qualified in its entirety by reference to the Agreement, a copy of which is filed as an exhibit to this filing. The Agreement has been attached as an exhibit to this report to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual information about HMH Sub, the Company or the Purchaser or any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Agreement were made only for the purposes of such agreement and as of specified dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. The representations and warranties may have been made for the purposes of allocating contractual risk between the parties to the agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the Agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of HMH Sub, the Company or the Purchaser or any of their respective subsidiaries or affiliates. In addition, the assertions embodied in the representations and warranties contained in the Agreement are qualified by information in a confidential disclosure schedule that the parties have exchanged. Accordingly, investors should not rely on the representations and warranties as characterizations of the actual state of facts, since (i) they were made only as of the date of such agreement or a prior, specified date, (ii) in some cases they are subject to qualifications with respect to materiality, knowledge and/or other matters and (iii) they may be modified in important part by the underlying disclosure schedule. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Agreement, which subsequent information may or may not be fully reflected in HMH Sub’s, the Company’s or the Purchaser’s public disclosures.

The Company is also filing herewith certain pro forma financial information related to the sale of the Business, which is attached hereto as Exhibit 99.1.

 

Item 7.01

Regulation FD Disclosure

On October 5, 2018, the Company issued a press release entitled “Houghton Mifflin Harcourt Updates Outlook to Reflect Completed Riverside Divestiture”. A copy of the press release is furnished herewith as Exhibit 99.2 to this report.

 

Item 9.01.

Financial Statements and Exhibits

(b) Pro Forma Financial Information.

The Unaudited Pro Forma Financial Statements of the Company reflecting the Closing of the sale of the Business are filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference:

 

i.

Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2018.

 

ii.

Unaudited Pro Forma Consolidated Statement of Operations for the six months ended June 30, 2018.

 

iii.

Unaudited Pro Forma Consolidated Statement of Operations for the year ended December 31, 2017.

 

iv.

Unaudited Pro Forma Consolidated Statement of Operations for the year ended December 31, 2016.

 

v.

Unaudited Pro Forma Consolidated Statement of Operations for the year ended December 31, 2015.

 

1


(d) Exhibits.

 

Exhibit No.

  

Description

2.1a†

   Asset Purchase Agreement, by and among Houghton Mifflin Harcourt Publishing Company, Houghton Mifflin Harcourt Company (solely for purposes of Section 8.2 and 8.3) and Riverside Assessment, LLC, dated as of September 12, 2018 (incorporated by reference from Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 12, 2018).

2.1b†

   Amendment No. 1 to Asset Purchase Agreement, by and among Houghton Mifflin Harcourt Publishing Company, Houghton Mifflin Harcourt Company (solely for purposes of Section  8.2 and 8.3) and Riverside Assessment, LLC, dated as of October 1, 2018.

99.1

   Unaudited pro forma condensed consolidated balance sheet as of June 30, 2018 and unaudited pro forma consolidated statement of operations for the six months ended June  30, 2018 and for the years ended December 31, 2017, December 31, 2016 and December 31, 2015.

99.2

   Press release dated October 5, 2018 titled “Houghton Mifflin Harcourt Updates Outlook to Reflect Completed Riverside Divestiture”

   Schedules and similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby undertakes to furnish supplementary copies of any of the omitted schedules or similar attachments upon request by the SEC.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HOUGHTON MIFFLIN HARCOURT COMPANY
By:   /s/ Joseph P. Abbott, Jr.
Name:   Joseph P. Abbott, Jr.
Title:   Executive Vice President and Chief Financial Officer

Dated: October 5, 2018

 

3

Exhibit 2.1b

AMENDMENT NO. 1

TO

ASSET PURCHASE AGREEMENT

This Amendment No. 1 to Asset Purchase Agreement, dated October 1, 2018 (this “ Amendment ”), is made by and between Riverside Assessments, LLC, a Delaware limited liability company (“ Buyer ”), and Houghton Mifflin Harcourt Publishing Company, a Massachusetts corporation (“ Seller ”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Purchase Agreement (as defined below).

WHEREAS , Buyer, Seller and, for certain limited purposes, Houghton Mifflin Harcourt Company, a Delaware corporation, entered into that certain Asset Purchase Agreement, dated September 12, 2018 (the “ Purchase Agreement ”);

WHEREAS , pursuant to Section 9.11 of the Purchase Agreement, (i) no amendment of any provision of the Purchase Agreement shall be valid unless the same shall be in writing and signed by both Buyer and Seller and (ii) no waiver granted under the Purchase Agreement shall be valid unless in writing and signed by the Party to be charged; and

WHEREAS , each of Buyer and Seller desires to amend the Purchase Agreement and the Disclosure Schedule as set forth herein;

NOW, THEREFORE , in consideration of the covenants and agreements contained in this Amendment and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:

 

1.

Amendment .

(a)    Section 1.1(d) of the Purchase Agreement is hereby amended to include the following subsection “(vii)”:

“(vii) all liabilities and obligations arising from any breach or alleged breach of Section 11A of the One Pierce Lease (as defined in Schedule 1.1(a)(ii) ) as a result of Buyer’s (or its employees’) occupancy or use of the leased real property described therein without the prior written consent of the landlord under the One Pierce Lease (the “ One Pierce Landlord ”) and any Landlord Consideration (defined below).

(b)    The following is hereby added at the end of Section 1.5 of the Purchase Agreement:

“Notwithstanding anything to the contrary in this Section  1.5 or Section  1.6 below, if the One Pierce Landlord conditions its grant of a consent to the assignment of the One Pierce Lease from Seller to Buyer (including by threatening to exercise a “recapture” or other termination right or denying consent) upon, or otherwise requires as a condition to granting such consent a “profit sharing” payment or other consideration (including increased rent payments, increased lease term or other


increased lease obligations) or the provision of additional security or a guaranty (collectively, to the extent approved as provided in this sentence, “ Landlord Consideration ”), Seller shall be solely responsible for making all such payments or providing all such additional security, provided that the terms thereof shall be subject to written approval by each of Seller and Buyer (such approval not to be unreasonably withheld, conditioned or delayed); and provided, further, however , that customary consent fees and reimbursement of legal fees incurred by the One Pierce Landlord required by the One Pierce Lease in respect of the assignment of the One Pierce Lease from Seller to Buyer shall be subject to the provisions of the penultimate sentence of this Section  1.5 .”

(c)    Section 4.2 of the Purchase Agreement shall be deleted in its entirety.

(d)    A new Section 8.9 shall be added to the Purchase Agreement as follows:

“8.9    Following the Closing, Buyer shall use its reasonable best efforts to arrange, as promptly as practicable following the Closing (such period following the Closing, the “ Replacement Period ”), to replace the letter of credit identified on Schedule 4.2 (collectively, the “ Letter of Credit ”). During the Replacement Period, Seller agrees to maintain the Letter of Credit in accordance with the requirement of the One Pierce Lease at Seller’s sole cost and expense.”

(e)    Item 1 of Section 2.10(c) of the Disclosure Schedule is hereby amended and restated to read in its entity as set forth on Annex A hereto.

 

2.

Miscellaneous .

(a)    Except as expressly set forth in this Amendment, the Purchase Agreement shall remain in full force and effect and the parties hereto ratify and confirm their agreements and covenants contained therein.

(b)    This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.

(c)    This Amendment shall be enforced, governed and construed in all respects in accordance with the laws of the State of Delaware.

(d)    This Amendment may be executed in counterparts and by facsimile signature, each of which shall be deemed an original and all of which taken together shall constitute one and the same instrument.

[Remainder of Page Intentionally Left Blank]


IN WITNESS WHEREOF , each of the Parties has executed this Amendment as of the date first written above.

 

BUYER:

 

RIVERSIDE ASSESSMENTS, LLC

By:

 

/s/ Rajib Roy

Name:

  Rajib Roy

Its:

  President & Chief Executive Officer

 

[Signature Page to Amendment No. 1 to the Purchase Agreement]


IN WITNESS WHEREOF , each of the Parties has executed this Amendment as of the date first written above.

 

SELLER:

 

HOUGHTON MIFFLIN HARCOURT

PUBLISHING COMPANY

By:

 

/s/ William F. Bayers

Name:

  William F. Bayers

Its:

  EVP, General Counsel & Secretary

 

[Signature Page to Amendment No. 1 to the Purchase Agreement]

Exhibit 99.1

Houghton Mifflin Harcourt Company

Unaudited Pro Forma Condensed Consolidated Financial Statements

On October 1, 2018, Houghton Mifflin Harcourt Publishing Company (“HMH Sub”), a wholly owned subsidiary of Houghton Mifflin Harcourt Company (the “Company” and together with HMH Sub, the “Sellers”) completed the previously announced sale of all of the assets, including intellectual property, used primarily in its Riverside clinical and standardized testing business (the “Business”) pursuant to the Asset Purchase Agreement, dated September 12, 2018 and as amended on October 1, 2018 (the “Agreement”) with Riverside Assessments, LLC (the “Purchaser”), for cash consideration received by the Sellers of approximately $140.0 million and the Purchaser’s assumption of all liabilities relating to the Business subject to specified exceptions (collectively, the “Transaction”). The results of the Business were previously reported in the Company’s Education segment.

The foregoing description is qualified in its entirety by reference to the Agreement, a copy of which is filed as an exhibit to the Company’s Current Report on Form 8-K filed on October 5, 2018.

The following unaudited pro forma condensed consolidated financial statements are presented to comply with Article 11 of Regulation S-X and follow prescribed SEC regulations. The unaudited condensed consolidated pro forma financial statements do not purport to present what the Company’s results would have been had the disposition actually occurred on the dates indicated or to project what the Company’s results of operations or financial position would have been for any future period. The prescribed regulations limit pro forma adjustments to those that are directly attributable to the disposition on a factually supported basis. Consequently, the Company was not permitted within the condensed consolidated pro forma financial statements to allocate to the disposed operations any indirect corporate overhead or costs, such as administrative corporate functions or any other costs that were shared with the retained business of the Company. As a result, such costs are not reflected in the pro forma adjustments and are included in the retained business of the Company. The pro forma adjustments are described in the notes to the unaudited condensed consolidated pro forma financial statements.

The unaudited condensed consolidated pro forma financial statements have been prepared for informational purposes and to assist in the analysis of the Company’s sale of the Business to the Purchaser. This information should be read together with the historical consolidated financial statements and related notes of Houghton Mifflin Harcourt Company included in its Annual Report on Form 10-K for the year ended December 31, 2017 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2018.

The unaudited pro forma condensed consolidated statements of operations for the six months ended June 30, 2018 and the years ended December 31, 2017, December 31, 2016 and December 31, 2015, assume the sale occurred on the first day of the earliest fiscal period presented. The unaudited pro forma condensed consolidated balance sheet as of June 30, 2018, assumes the sale occurred on June 30, 2018. The unaudited pro forma condensed consolidated financial statements are derived from the historical consolidated financial statements of the Company and are based on assumptions that management believes are reasonable in the circumstances.


Houghton Mifflin Harcourt Company

Pro Forma Condensed Consolidated Balance Sheets (Unaudited)

At June 30, 2018

 

(in thousands of dollars)    HMH      Pro Forma
Adjustments
           HMH Pro
Forma
 

Assets

          

Current assets

          

Cash and cash equivalents

   $ 30,709      $ 135,015       A      $ 165,724  

Accounts receivable, net

     293,693        (6,047     B        287,646  

Inventories

     212,436        (4,075     B        208,361  

Prepaid expenses and other assets

     30,888        (600     B        30,288  
  

 

 

    

 

 

      

 

 

 

Total current assets

     567,726        124,293          692,019  

Property, plant, and equipment, net

     149,137        (5,233     B        143,904  

Pre-publication costs, net

     341,474        (11,206     B        330,268  

Royalty advances to authors, net

     49,964                 49,964  

Goodwill

     783,073        (70,000     B        713,073  

Other intangible assets, net

     578,133        (27,375     B        550,758  

Deferred income taxes

     3,593                 3,593  

Deferred commissions

     22,598                 22,598  

Other assets

     28,658                 28,658  
  

 

 

    

 

 

      

 

 

 

Total assets

   $ 2,524,356      $ 10,479        $ 2,534,835  
  

 

 

    

 

 

      

 

 

 

Liabilities and Stockholders’ Equity

          

Current liabilities

          

Revolving credit facility

   $ 50,000      $      $ 50,000  

Current portion of long-term debt

     8,000                 8,000  

Accounts payable

     94,920        (1,266     B        93,654  

Royalties payable

     67,085        (4,902     B        62,183  

Salaries, wages, and commissions payable

     39,938        (1,117     B        38,821  

Deferred revenue

     240,355        (6,486     B        233,869  

Interest payable

     293                 293  

Severance and other charges

     6,760                 6,760  

Accrued postretirement benefits

     1,618                 1,618  

Other liabilities

     30,378        (1,954     B        28,424  
  

 

 

    

 

 

      

 

 

 

Total current liabilities

     539,347        (15,725        523,622  

Long-term debt, net of discount and issuance costs

     757,922                 757,922  

Long-term deferred revenue

     400,803        (260     B        400,543  

Accrued pension benefits

     23,476                 23,476  

Accrued postretirement benefits

     19,041                 19,041  

Deferred income taxes

     28,144        (1,050     B        27,094  

Other liabilities

     21,364        (2,167     B        19,197  
  

 

 

    

 

 

      

 

 

 

Total liabilities

     1,790,097        (19,202        1,770,895  
  

 

 

    

 

 

      

 

 

 

Stockholders’ equity

     734,259        29,681       C        763,940  
  

 

 

    

 

 

      

 

 

 

Total liabilities and stockholders’ equity

   $ 2,524,356      $ 10,479        $ 2,534,835  
  

 

 

    

 

 

      

 

 

 

See the accompanying notes which are an integral part of these unaudited pro forma condensed consolidated financial statements.


Houghton Mifflin Harcourt Company

Pro Forma Consolidated Statements of Operations (Unaudited)

Six Months Ended June 30, 2018

 

(in thousands of dollars, except per share data)    HMH     Pro Forma
Adjustments
         HMH Pro
Forma
 

Net sales

   $ 595,349     $ (38,225   D    $ 557,124  

Costs and expenses

         

Cost of sales, excluding publishing rights and pre-publication amortization

     272,921       (13,130   D      259,791  

Publishing rights amortization

     18,238                18,238  

Pre-publication amortization

     54,315       (2,362   D      51,953  
  

 

 

   

 

 

      

 

 

 

Cost of sales

     345,474       (15,492        329,982  

Selling and administrative

     325,006       (10,156   D      314,850  

Other intangible asset amortization

     14,292       (750   D      13,542  

Severance and other charges

     6,018                6,018  

Loss on sale of assets

     384                384  
  

 

 

   

 

 

      

 

 

 

Operating loss

     (95,825     (11,827        (107,652
  

 

 

   

 

 

      

 

 

 

Other income (expense)

         

Retirement benefits non-service income

     640                640  

Interest expense

     (22,408              (22,408

Interest income

     623                623  

Change in fair value of derivative instruments

     (725              (725
  

 

 

   

 

 

      

 

 

 

Loss before taxes

     (117,695     (11,827        (129,522

Income tax expense

     6,888       (1,435   E      5,453  
  

 

 

   

 

 

      

 

 

 

Net loss

   $ (124,583   $ (10,392      $ (134,975
  

 

 

   

 

 

      

 

 

 

Net loss per share attributable to common stockholders

         

Basic

   $ (1.01        $ (1.09
  

 

 

        

 

 

 

Diluted

   $ (1.01        $ (1.09
  

 

 

        

 

 

 

See the accompanying notes which are an integral part of these unaudited pro forma condensed consolidated financial statements.


Houghton Mifflin Harcourt Company

Pro Forma Consolidated Statements of Operations (Unaudited)

Year Ended December 31, 2017

 

(in thousands of dollars, except per share data)    HMH     Pro Forma
Adjustments
         HMH Pro
Forma
 

Net sales

   $ 1,407,511     $ (80,482   D    $ 1,327,029  

Costs and expenses

         

Cost of sales, excluding publishing rights and pre-publication amortization

     617,802       (29,284   D      588,518  

Publishing rights amortization

     46,238                46,238  

Pre-publication amortization

     126,038       (6,130   D      119,908  
  

 

 

   

 

 

      

 

 

 

Cost of sales

     790,078       (35,414        754,664  

Selling and administrative

     658,346       (22,020   D      636,326  

Other intangible asset amortization

     30,748       (1,500   D      29,248  

Impairment charge for pre-publication costs

     3,980                3,980  

Restructuring

     40,653       (2,878   D      37,775  

Severance and other charges

     713       (536   D      177  
  

 

 

   

 

 

      

 

 

 

Operating loss

     (117,007     (18,134        (135,141
  

 

 

   

 

 

      

 

 

 

Other income (expense)

         

Retirement benefits non-service income

     3,486                3,486  

Interest expense

     (42,805              (42,805

Interest income

     1,338                1,338  

Change in fair value of derivative instruments

     1,366                1,366  
  

 

 

   

 

 

      

 

 

 

Loss before taxes

     (153,622     (18,134        (171,756

Income tax (benefit) expense

     (50,435     19,280     E      (31,155
  

 

 

   

 

 

      

 

 

 

Net loss

   $ (103,187   $ (37,414      $ (140,601
  

 

 

   

 

 

      

 

 

 

Net loss per share attributable to common stockholders

         

Basic

   $ (0.84        $ (1.14
  

 

 

        

 

 

 

Diluted

   $ (0.84        $ (1.14
  

 

 

        

 

 

 

See the accompanying notes which are an integral part of these unaudited pro forma condensed consolidated financial statements.


Houghton Mifflin Harcourt Company

Pro Forma Consolidated Statements of Operations (Unaudited)

Year Ended December 31, 2016

 

(in thousands of dollars, except per share data)    HMH     Pro Forma
Adjustments
         HMH Pro
Forma
 

Net sales

   $ 1,372,685     $ (80,707   D    $ 1,291,978  

Costs and expenses

         

Cost of sales, excluding publishing rights and pre-publication amortization

     610,715       (32,398   D      578,317  

Publishing rights amortization

     61,351                61,351  

Pre-publication amortization

     130,243       (8,377   D      121,866  
  

 

 

   

 

 

      

 

 

 

Cost of sales

     802,309       (40,775        761,534  

Selling and administrative

     703,797       (22,627   D      681,170  

Other intangible asset amortization

     26,750       (375   D      26,375  

Impairment charge for intangible assets

     139,205       (9,000   D      130,205  

Restructuring

                     

Severance and other charges

     15,650       (279   D      15,371  
  

 

 

   

 

 

      

 

 

 

Operating loss

     (315,026     (7,651        (322,677
  

 

 

   

 

 

      

 

 

 

Other income (expense)

         

Retirement benefits non-service income

     4,253                4,253  

Interest expense

     (39,181              (39,181

Interest income

     518                518  

Change in fair value of derivative instruments

     (614              (614
  

 

 

   

 

 

      

 

 

 

Loss before taxes

     (350,050     (7,651        (357,701

Income tax (benefit) expense

     (65,492     13,936     E      (51,556
  

 

 

   

 

 

      

 

 

 

Net loss

   $ (284,558   $ (21,587      $ (306,145
  

 

 

   

 

 

      

 

 

 

Net loss per share attributable to common stockholders

         

Basic

   $ (2.32        $ (2.50
  

 

 

        

 

 

 

Diluted

   $ (2.32        $ (2.50
  

 

 

        

 

 

 

See the accompanying notes which are an integral part of these unaudited pro forma condensed consolidated financial statements.


Houghton Mifflin Harcourt Company

Pro Forma Consolidated Statements of Operations (Unaudited)

Year Ended December 31, 2015

 

(in thousands of dollars, except per share data)    HMH     Pro Forma
Adjustments
         HMH Pro
Forma
 

Net sales

   $ 1,416,059     $ (96,643   D    $ 1,319,416  

Costs and expenses

         

Cost of sales, excluding publishing rights and pre-publication amortization

     622,668       (40,257   D      582,411  

Publishing rights amortization

     81,007                81,007  

Pre-publication amortization

     120,506       (7,614   D      112,892  
  

 

 

   

 

 

      

 

 

 

Cost of sales

     824,181       (47,871        776,310  

Selling and administrative

     683,911       (28,024   D      655,887  

Other intangible asset amortization

     22,038                22,038  

Severance and other charges

     4,767       (621   D      4,146  
  

 

 

   

 

 

      

 

 

 

Operating loss

     (118,838     (20,127        (138,965
  

 

 

   

 

 

      

 

 

 

Other income (expense)

         

Retirement benefits non-service income

     2,787                2,787  

Interest expense

     (32,254              (32,254

Interest income

     209                209  

Change in fair value of derivative instruments

     (2,362              (2,362

Loss on extinguishment of debt

     (3,051              (3,051
  

 

 

   

 

 

      

 

 

 

Loss before taxes

     (153,509     (20,127        (173,636

Income tax (benefit) expense

     (19,640     (771   E      (20,411
  

 

 

   

 

 

      

 

 

 

Net loss

   $ (133,869   $ (19,356      $ (153,225
  

 

 

   

 

 

      

 

 

 

Net loss per share attributable to common stockholders

         

Basic

   $ (0.98        $ (1.12
  

 

 

        

 

 

 

Diluted

   $ (0.98        $ (1.12
  

 

 

        

 

 

 

See the accompanying notes which are an integral part of these unaudited pro forma condensed consolidated financial statements.


1. Description of Transaction

On October 1, 2018, Houghton Mifflin Harcourt Publishing Company (“HMH Sub”), a wholly owned subsidiary of Houghton Mifflin Harcourt Company (the “Company” and together with HMH Sub, the “Sellers”) closed the previously announced sale of all of the assets, including intellectual property, used primarily in its Riverside clinical and standardized testing business (the “Business”) pursuant to the Asset Purchase Agreement, dated September 12, 2018 and as amended on October 1, 2018 (the “Agreement”) with Riverside Assessments, LLC (the “Purchaser”), for cash consideration received by the Sellers of approximately $140.0 million and the Purchaser’s assumption of all liabilities relating to the Business subject to specified exceptions (collectively, the “Transaction”).

2. Pro Forma Adjustments

The pro forma adjustments made to the historical condensed consolidated financial statements of the Company are described as follows:

 

A.

Reflects proceeds of $140.0 million received in cash from the sale adjusted for the expenses related to the Transaction of approximately $5.0 million.

 

B.

Reflects the adjustments to eliminate the assets and liabilities sold related to the Business. Goodwill represents a preliminary estimate of fair value of the Business relative to other components of the Company’s business.

 

C.

Represents the cash proceeds of the transaction and the net asset value transferred to the Purchaser.

 

D.

Represents the revenue and expenses directly attributable to the Business operations. The pro forma adjustments exclude the indirect and fixed costs allocated to the sold business.

 

E.

The effective tax rates differ from the blended federal and state statutory rate of 26.2% for the six months ended June 30, 2018, 26.4%, 39.3% and 38.7% for the years ended December 31, 2017, 2016 and 2015, respectively. Differences are due to the reclassification of intangibles from indefinite-lived to definite-lived and the effects of an impairment on indefinite-lived intangible assets during the year ended December 31, 2016, and the impact of US Tax Reform for the year ended December 31, 2017.

LOGO

Exhibit 99.2

Houghton Mifflin Harcourt Updates Outlook to Reflect Completed Riverside Divestiture

BOSTON – Oct. 5, 2018 – Global learning company Houghton Mifflin Harcourt (HMH) (Nasdaq: HMHC) on Monday, October 1, 2018, completed its previously announced agreement to divest its Riverside clinical and standardized testing (Riverside) portfolio to private equity firm Alpine Investors for a purchase price of $140 million. Net proceeds to HMH were approximately $135 million after transaction fees.

The completion of the transaction enables HMH to sharpen its focus on developing and delivering next generation K-12 classroom offerings rooted in learning science that seamlessly combine teacher support, data-driven instructional practices, intervention solutions and focused content architecture to accelerate growth for all learners.

As stated at the time of announcement, HMH plans to invest the net proceeds in its Extensions businesses, supporting its overarching strategy to create integrated solutions and improve student outcomes.

New 2018 Outlook Reflecting Divestiture

As a result of the transaction, HMH revised its outlook for 2018. The Company’s outlook for its continuing operations is unchanged, and the revision reflects changes resulting from the transaction only. HMH now expects 2018 net sales to be in a range of $1.270 to $1.350 billion and billings to be in the range of $1.285 to $1.365 billion. Content development spend for 2018 is expected to be in the range of $117 to $142 million, with total capital expenditures including non-plate capital expenditures in the range of $174 to $199 million. HMH continues to expect 2018 free cash flow from continuing operations to be negative (but improved from 2017 free cash flow from continuing operations) at the midpoint of the revised billings guidance range. In 2017, giving pro forma effect to the transaction as if it had occurred on January 1, 2017, HMH’s adjusted fixed and variable costs as a percentage of billings were 48% and 39%, respectively. For 2018, the Company expects its adjusted fixed and variable costs as a percentage of billings to be comparable to pro forma 2017 adjusted costs at the midpoint of the revised billings guidance range.

About Houghton Mifflin Harcourt

Houghton Mifflin Harcourt (NASDAQ:HMHC) is a global learning company committed to delivering integrated solutions that engage learners, empower educators and improve student outcomes. As a leading provider of K–12 core curriculum, supplemental and intervention solutions and professional learning services, HMH partners with educators and school districts to uncover solutions that unlock students’ potential and extend teachers’ capabilities. HMH serves more than 50 million students and 3 million educators in 150 countries, while its award-winning children’s books, novels, non-fiction, and reference titles are enjoyed by readers throughout the world. For more information, visit www.hmhco.com.

Use of Non-GAAP Financial Measures:

To provide additional insight into our performance we have presented free cash flow from continuing operations, which is defined as net cash from continuing operating activities minus capital expenditures. This measure is not prepared in accordance with GAAP. This information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for financial information prepared in accordance with GAAP. Management believes that the presentation of free cash flow from continuing operations provides useful information to our investors because management regularly reviews this measure as an important indicator of how much cash is generated by general business operations, excluding capital expenditures, and makes decisions based on it. Although we use this non-GAAP measure to assess our business, the use of non-GAAP measures is limited as they include and/or do not include certain items not included and/or included in the most directly comparable GAAP measure. Management is unable to present a quantitative reconciliation of free cash flow from continuing operations to the most directly comparable GAAP financial measure of net cash provided by operating activities because management cannot reliably predict all of the necessary components of such GAAP measure on a forward-looking basis.


Forward-Looking Statements

This news release contains certain statements that are not historical facts, including information regarding our intentions, beliefs or current expectations concerning, among other things, the expected impact of the transaction described above, our results of operations, financial condition, liquidity, prospects, growth, strategies, the industry in which we operate and potential business decisions. Those statements constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the results expressed in or implied by our forward-looking statements, including, but not limited to, changes in state and local education funding and/or related programs, legislation and procurement processes; adverse or worsening economic trends or the continuation of current economic conditions; changes in consumer demand for, and acceptance of, our products; industry cycles and trends; conditions and/or changes in the publishing industry; and other factors discussed in our news releases, public statements and/or filings with the U.S. Securities and Exchange Commission, including our most recent Annual and Quarterly Reports on Form 10-K and Form 10-Q. We undertake no obligation, and do not expect, to publicly update or publicly revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact

Investors

Brian S. Shipman, CFA

Senior Vice President, Investor Relations

(212) 592-1177

brian.shipman@hmhco.com

Media

Bianca Olson

Senior Vice President, Corporate Affairs

(617) 351-3841

bianca.olson@hmhco.com